SPP1 and hepatocellular carcinoma: Furthermore, a meta-analysis including 12 studies consisting of 1191 controls and 1235 patients with HCC concluded that the sensitivity of SPP1 was higher than that of AFP and that SPP1 was a comparable biomarker to AFP for the diagnosis of HCC and the combination of SPP1 and AFP could improve the sensitivity of early HCC diagnosis 63.